lifestyle.thedishh.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
AVACTA GROUP PLC
Avacta Announces Two Key Clinical Updates to its Faridoxorubicin Program
February 7, 2026
Avacta Announces U.S. Food and Drug Administration Clearance of the Investigational New Drug (IND) Application for the Second pre|CISION® Medicine, FAP-Exatecan (AVA6103)
January 21, 2026
Avacta Announces Year-end Trading Update
January 20, 2026